Patents by Inventor Ramaroson Andriantsitohaina

Ramaroson Andriantsitohaina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9987327
    Abstract: The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: June 5, 2018
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE MONTPELLIER, ASSITANCE PUBLIQUE—HOPITAUX DE PARIS, UNIVERSITE PARIS EST CRETEIL VAL DE MARNE, UNIVERSITE D'ANGERS
    Inventors: Alain Lacampagne, Jerome Thireau, Olivier Cazorla, Jean-Yves Le Guennec, Jeremy Fauconnier, Maria del Carmen Martinez, Ramaroson Andriantsitohaina, Bijan Ghaleh-Marzban, Raffaella Soleti
  • Publication number: 20170049854
    Abstract: The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
    Type: Application
    Filed: October 17, 2016
    Publication date: February 23, 2017
    Inventors: Alain LACAMPAGNE, Jerome THIREAU, Olivier CAZORLA, Jean-Yves LE GUENNEC, Jeremy FAUCONNIER, Maria del Carmen MARTINEZ, Ramaroson ANDRIANTSITOHAINA, Bijan GHALEH-MARZBAN, Raffaella SOLETI
  • Patent number: 9504732
    Abstract: The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
    Type: Grant
    Filed: January 14, 2014
    Date of Patent: November 29, 2016
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE MONTPELLIER, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, UNIVERSITE PARIS EST CRETEIL VAL DE MARNE
    Inventors: Alain Lacampagne, Jerome Thireau, Olivier Cazorla, Jean-Yves Le Guennec, Jeremy Fauconnier, Maria del Carmen Martinez, Ramaroson Andriantsitohaina, Bijan Ghaleh-Marzban, Raffaella Soleti
  • Publication number: 20150352182
    Abstract: The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
    Type: Application
    Filed: January 14, 2014
    Publication date: December 10, 2015
    Inventors: Alain LACAMPAGNE, Jerome THIREAU, Olivier CAZORLA, Jean-Yves LE GUENNEC, Jeremy FAUCONNIER, Maria del Carmen MARTINEZ, Ramaroson ANDRIANTSITOHAINA, Bijan GHALEH-MARZBAN, Raffaella SOLETI
  • Publication number: 20080139486
    Abstract: The invention concerns a composition for implementing a preventive therapeutic treatment method against restenosis, characterized in that it comprises 60 to 80 wt. % of compounds of the flavonol family. The composition is useful for implementing a preventive therapeutic treatment method against restenosis and atheromatous disease in coronary patients.
    Type: Application
    Filed: June 15, 2005
    Publication date: June 12, 2008
    Inventors: Ramaroson Andriantsitohaina, Gerald Roul